[1]
Renzi, A. et al. 2015. COX and VEGFR-2 inhibitors as potentiating agents of new HDAC inhibitors as epigenetic modulators in cancer. Italian Journal of Anatomy and Embryology. 119, 1 (Mar. 2015), 163.